Epidemiology of oral human papillomavirus infection
- PMID: 24080455
- PMCID: PMC3968244
- DOI: 10.1016/j.oraloncology.2013.09.003
Epidemiology of oral human papillomavirus infection
Abstract
Objective: To describe what is known about the epidemiology of oral human papillomavirus (HPV) infection.
Methods: In this article we review current data on HPV prevalence, natural history, mode of acquisition, and risk factors for oral HPV infection.
Results & conclusion: Over the past several years new studies have informed our understanding of oral HPV infection. These data suggest oral HPV prevalence is higher in men than women and support the sexual transmission of HPV to the mouth by oral sex. Data is emerging suggesting that most oral HPV infections usually clear within a year on and describing risk factors for prevalent and persistent infection. Recent data support likely efficacy of the HPV vaccine for oral HPV, suggesting vaccination may reduce risk of HPV-related oropharyngeal cancer.
Keywords: Human papillomavirus; Incidence; Natural history; Oral infection; Oropharynx cancer; Prevalence.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Prevalence of oral HPV infection in the United States, 2009-2010.JAMA. 2012 Feb 15;307(7):693-703. doi: 10.1001/jama.2012.101. Epub 2012 Jan 26. JAMA. 2012. PMID: 22282321 Free PMC article.
-
Rates and determinants of oral human papillomavirus infection in young men.Sex Transm Dis. 2012 Nov;39(11):860-7. doi: 10.1097/OLQ.0b013e318269d098. Sex Transm Dis. 2012. PMID: 23064535 Free PMC article.
-
Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men.Sex Transm Dis. 2013 Jan;40(1):3-10. doi: 10.1097/OLQ.0b013e31827e87bd. Sex Transm Dis. 2013. PMID: 23250297
-
National prevalence of oral HPV infection and related risk factors in the U.S. adult population.Oral Dis. 2012 Jul;18(5):430-41. doi: 10.1111/j.1601-0825.2011.01892.x. Epub 2012 Jan 18. Oral Dis. 2012. PMID: 22251072 Review.
-
Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages.Expert Rev Anti Infect Ther. 2014 Aug;12(8):947-57. doi: 10.1586/14787210.2014.922872. Epub 2014 May 28. Expert Rev Anti Infect Ther. 2014. PMID: 24865412 Review.
Cited by
-
Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma of the Head and Neck: A Growing Epidemic.Adolesc Med State Art Rev. 2014 Aug;25(2):489-501. Adolesc Med State Art Rev. 2014. PMID: 27132327 Free PMC article.
-
High prevalent human papillomavirus infections of the oral cavity of asymptomatic HIV-positive men.BMC Infect Dis. 2020 Jan 10;20(1):27. doi: 10.1186/s12879-019-4677-9. BMC Infect Dis. 2020. PMID: 31924186 Free PMC article.
-
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res. 2018 May 1;78(9):2383-2395. doi: 10.1158/0008-5472.CAN-17-1672. Epub 2018 Feb 12. Cancer Res. 2018. PMID: 29440171 Free PMC article.
-
Lack of knowledge regarding HPV and its relation to oropharyngeal cancer among medical students.Cancer Rep (Hoboken). 2022 Jul;5(7):e1517. doi: 10.1002/cnr2.1517. Epub 2021 Jul 22. Cancer Rep (Hoboken). 2022. PMID: 34291614 Free PMC article.
-
Genomic insights into head and neck cancer.Cancers Head Neck. 2016;1:1. doi: 10.1186/s41199-016-0003-z. Epub 2016 Jun 3. Cancers Head Neck. 2016. PMID: 29034103 Free PMC article.
References
-
- Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med. 2011;53(Suppl 1):S12–21. - PubMed
-
- Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–20. - PubMed
-
- D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–56. - PubMed
-
- Bouvard V, Baan R, Straif K, et al. A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009;10:321–2. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous